Epothilones, commonly referred to as macrolide compounds, were initially discovered in 1987 from the fermentation products of soil bacteria. They are a group of anti-cancer drugs with high potency. Judging from the characteristics of their chemical structures, epothilones can be divided into two classes based on the functional groups on their C12 to C13 positions: epoxide epothilones (epoxides).Using our advanced full synthesis ``DrugLnk'' platform for antibody-drug conjugate (ADC) development, Creative Biolabs offers epothilones conjugated ADCs with the most suitable linkers and optimized conjugation strategies to serve clients' specific requirements.